These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 22185135)

  • 1. Metabolic studies with deuterated phenobarbital.
    Perel JM; Dayton PG; Tauriello CL; Brand L; Mark LC
    J Med Chem; 1967 May; 10(3):371-4. PubMed ID: 22185135
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of dimethoxymethyl phenobarbital (eterobarb) in patients with epilepsy.
    Goldberg MA; Gal J; Cho AK; Jenden DJ
    Ann Neurol; 1979 Feb; 5(2):121-6. PubMed ID: 426475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological uses and perspectives of heavy water and deuterated compounds.
    Kushner DJ; Baker A; Dunstall TG
    Can J Physiol Pharmacol; 1999 Feb; 77(2):79-88. PubMed ID: 10535697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic fate of phenobarbital in man. N-Glucoside formation.
    Tang BK; Kalow W; Grey AA
    Drug Metab Dispos; 1979; 7(5):315-8. PubMed ID: 40773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine.
    Leclercq V; Desager JP; Horsmans Y; Van Nieuwenhuyze Y; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of tinea microsporum. Metabolic interference between phenobarbital and griseofulvin].
    Beurey J; Weber M; Vignaud JM
    Ann Dermatol Venereol; 1982; 109(6-7):567-70. PubMed ID: 7187184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic-intermediate complex formation reveals major changes in rat hepatic cytochrome P-450 subpopulations in addition to those forms previously purified after phenobarbital, beta-naphthoflavone, and isosafrole induction.
    Bornheim LM; Franklin MR
    Mol Pharmacol; 1982 Mar; 21(2):527-32. PubMed ID: 7099151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of phenobarbital on thiopental pharmacokinetics in greyhounds.
    Sams RA; Muir WW
    Am J Vet Res; 1988 Feb; 49(2):245-9. PubMed ID: 3348533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of phenobarbital N-glucuronides as urinary metabolites of phenobarbital in mice.
    Neighbors SM; Soine WH
    Drug Metab Dispos; 1995 May; 23(5):548-52. PubMed ID: 7587929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response behavior of the induction of alpha 1-acid glycoprotein by phenobarbital in the dog.
    Abramson FP
    Drug Metab Dispos; 1988; 16(4):546-50. PubMed ID: 2903021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute primidone overdosage with massive crystalluria.
    Cate JC IV; Tenser R
    Clin Toxicol; 1975; 8(4):385-9. PubMed ID: 1220892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cloning, sequencing, and functional studies of phenobarbital-inducible forms of cytochrome P450 2B and 4B expressed in rabbit kidney.
    Ryan R; Grimm SW; Kedzie KM; Halpert JR; Philpot RM
    Arch Biochem Biophys; 1993 Aug; 304(2):454-63. PubMed ID: 8346920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of a deficiency of steroid delta 4-5 alpha-reductase activity in liver by a porphyrinogenic drug.
    Kappas A; Bradlow HL; Bickers DR; Alvares AP
    J Clin Invest; 1977 Jan; 59(1):159-64. PubMed ID: 830660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritive value of N-acetyl-L-tryptophan in man.
    Wegmann H; Curtius HC; Gitzelmann R; Otten A
    Helv Paediatr Acta; 1979; 34(5):497-508. PubMed ID: 93590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biosynthesis and characterization of deuterated polyhydroxyoctanoate.
    Foster LJ; Russell RA; Sanguanchaipaiwong V; Stone DJ; Hook JM; Holden PJ
    Biomacromolecules; 2006 Apr; 7(4):1344-9. PubMed ID: 16602759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activity of the liver monooxygenase system after induction with phenobarbital in the early neonatal period].
    Guliaeva LF; Mishin VM
    Vopr Med Khim; 1985; 31(5):49-53. PubMed ID: 3937330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metabolic bone disturbance in children treated with phenobarbital (author's transl)].
    Paucić-Kirincić E; Kriz M; Gazdik M
    Lijec Vjesn; 1980 Apr; 102(4):199-201. PubMed ID: 7464437
    [No Abstract]   [Full Text] [Related]  

  • 18. Individualizing phenobarbital dosing in neonates.
    Gilman ME; Toback JW; Gal P; Erkan NV
    Clin Pharm; 1983; 2(3):258-62. PubMed ID: 6883954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital in the genetically obese Zucker rat. II. In vivo and in vitro assessments of microsomal enzyme induction.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):654-9. PubMed ID: 6502519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenobarbital in the genetically obese Zucker rat. I. Pharmacokinetics after acute and chronic administration.
    Brouwer KL; Kostenbauder HB; McNamara PJ; Blouin RA
    J Pharmacol Exp Ther; 1984 Dec; 231(3):649-53. PubMed ID: 6502518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.